Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $1.21 in the prior trading day, IN8bio Inc (NASDAQ: INAB) closed at $1.55, up 28.10%. In other words, the price has increased by $28.10 from its previous closing price. On the day, 0.74 million shares were traded. INAB stock price reached its highest trading level at $1.58 during the session, while it also had its lowest trading level at $1.2.
Ratios:
Our goal is to gain a better understanding of INAB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.91 and its Current Ratio is at 6.91. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.14.
Upgrades & Downgrades
In the most recent recommendation for this company, Laidlaw on March 18, 2024, initiated with a Buy rating and assigned the stock a target price of $7.50.
On August 30, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $14.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INAB now has a Market Capitalization of 7183313 and an Enterprise Value of -548686.
Stock Price History:
The Beta on a monthly basis for INAB is 0.05, which has changed by -0.8283688 over the last 52 weeks, in comparison to a change of 0.13153219 over the same period for the S&P500. Over the past 52 weeks, INAB has reached a high of $12.53, while it has fallen to a 52-week low of $1.17. The 50-Day Moving Average of the stock is -14.31%, while the 200-Day Moving Average is calculated to be -49.09%.
Shares Statistics:
The stock has traded on average 236.78K shares per day over the past 3-months and 1123210 shares per day over the last 10 days, according to various share statistics. A total of 4.59M shares are outstanding, with a floating share count of 4.20M. Insiders hold about 9.36% of the company’s shares, while institutions hold 17.29% stake in the company. Shares short for INAB as of 1764288000 were 21609 with a Short Ratio of 0.09, compared to 1761868800 on 9565. Therefore, it implies a Short% of Shares Outstanding of 21609 and a Short% of Float of 0.52.
Earnings Estimates
The dynamic stock of IN8bio Inc (INAB) is currently being evaluated by a team of 1.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$1.2, with high estimates of -$1.2 and low estimates of -$1.2.
Analysts are recommending an EPS of between -$4.46 and -$4.54 for the fiscal current year, implying an average EPS of -$4.5. EPS for the following year is -$3.48, with 5.0 analysts recommending between -$1.36 and -$5.7.
